NIH study finds long-acting injectable drug prevents HIV acquisition in cisgender women
National Institutes of Health (NIH) sent this bulletin at 11/09/2020 11:30 AM ESTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
11/09/2020 11:15 AM EST
Long-acting regimen more effective than daily oral pill among African women.